Application of fibrin glue to prevent seroma at the donor site of free transverse myocutaneous gracilis flaps

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032662

Enrollment

Registered

2025-02-19

Start date

2023-11-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative seroma

Interventions

Group 1: Intervention group: Closure of the donor site in transverse myocutaneous gracilis (TMG) flaps with additional use of fibrin glue. Group 2: Control group: Closure of the donor site in transver

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Female patients undergoing breast reconstruction using the transverse myocutaneous gracilis (TMG) flap Provision of written informed consent

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the study Patients with a history of previous surgery at the donor site

Design outcomes

Primary

Measure	Time frame
Postoperative volume of secreted wound fluid in the area of ??the TMG donor site	—

Secondary

Measure	Time frame
Number of seroma punctures in the area of ??the TMG donor site Amount of punctured seroma fluid in the area of ??the TMG donor site Time until drainage pull Discharge with drainage secondary complications due to the seromas that have arisen in the area of ??the TMG donor site	—

Countries

Germany

Contacts

Public ContactUli Dirk Haide

Isar Klinikum München

ulidirk.haide@isarklinikum.de+49 891499037701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026